Developer docs
API playgroundTry for free, no card

Search company profiles

CryoDAO

Full company profile

uuid00sc3ym

Namestring
CryoDAO
Legal namestring
CryoDAO
Websiteurl
cryodao.org
Company typeenum
Private
Founded yearint
2022
Descriptiontext

CryoDAO is a decentralized autonomous organization (DAO) registered as a non-profit association in Basel, Switzerland, that funds high-impact cryopreservation, biostasis, and cryobiology research through token-based community governance. The organization operates within the decentralized science (DeSci) ecosystem, with holders of the CRYO governance token proposing and voting on research funding allocations via Snapshot and on-chain voting. Its treasury exceeds $5 million, its community spans 6,000+ members across Discord and Twitter/X, and its CRYO token trades on Uniswap (Ethereum mainnet) and Aerodrome (Base chain).

The organization's core products are the CRYO governance token and the IP-NFT framework for tokenizing and community-governing research intellectual property. To date CryoDAO has funded nine research projects including CRYORAT ($900K for high-subzero preservation and revival of a rat, led by Advanced Neural Biosciences), Live Births from Vitrified Ovaries ($350K with Gaia Life and NIH co-funding), the American Biostasis Foundation STASIS facility ($100K, Comfort Texas), the CPA Repository ($52K), a Space Mice embryo cryopreservation project ($17.5K), the Multi-Organ Cryopreservation HIFU project (€50K), and the CryoDAO Fellowship program ($100-$3,000 micro-grants). Strategic scientific and operational partners include VitaDAO, Tomorrow Bio, Cryopets, European Biostasis Foundation, Oxford Cryotechnology, Advanced Neural Biosciences, and Gaia Life; the co-founder team includes Dr. Emil Kendziorra (CEO of Tomorrow Bio), Kai Micah Mills (Founder & CEO of Cryopets, Thiel Fellow), Eli Mohamad (X-Therma), and Vincent Weisser (co-initiator of VitaDAO & BIO).

CryoDAO does not generate traditional revenue and does not operate a conventional pricing model. Its economic model relies on token-based governance participation, potential returns from IP-NFT commercialization and licensing rights acquired from funded projects (which may flow back to the treasury), and treasury investment management. The Fellowship program is a non-dilutive micro-grant mechanism; the DAO does not take equity or IP in fellowship recipients. Primary stakeholder segments are cryopreservation researchers and scientists, DeFi/crypto community members holding CRYO for governance participation, and longevity and life-extension enthusiasts. Geographic restrictions under Regulation S limit CRYO token holdings by US persons, narrowing the addressable US retail market.

Short descriptiontext

CryoDAO is a Basel-registered decentralized autonomous organization that funds cryopreservation and biostasis research through community governance, serving researchers and longevity-focused crypto community members with a $5M+ treasury across nine funded projects.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZug, Switzerland
HQ citystring
Zug
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized science funding, cryopreservation research grants, DAO governance infrastructure, biostasis research platform, intellectual property NFTs
Industry4 codes
PRIMARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
NAICS code1 code
  • Grantmaking Foundations813211
SIC code1 code
  • Finance Services6199
Product category
Decentralized Science Funding
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Treasury Investment Returns
TypeLicensing Royalties
Description

In return for funding research, CryoDAO may receive IP/commercialization rights and/or equity. Value created through funded projects flows back into the DAO to fund more research.

cryodao.org
2Token-Based Governance
TypeSubscription Recurring
Description

CRYO token serves as governance token for DAO membership. Value accrues to token holders through successful project outcomes and IP-NFT spinouts.

cryodao.org
3IP-NFT Token Sales
TypeTransaction Fee
Description

IP-NFT launch generates proceeds through token sales. 50% of funds raised become immediately available for CryoDAO Treasury, the rest funds sub-DAO operating budget.

cryodao.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Others
Pricing details1 tier
1CryoDAO Fellowship micro-grants
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Micro-grants between $100-$3,000 for scientists, students, and cryopreservation enthusiasts. Funds can be used for research, travel, education, and more. No equity or IP taken.

cryodao.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CryoDAO is a Decentralized Autonomous Organization that funds cryopreservation, biostasis, and cryobiology research through community-governed treasury allocation. It operates the CRYO governance token, an IP-NFT framework that tokenizes intellectual property from funded research for community ownership, and a fellowship program providing micro-grants to researchers. Revenue flows back to the DAO from treasury investment returns and IP/commercialization royalties from funded projects.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 6+ research projects funded with over $1.5M in total funding allocated
Product overview1 text field

CryoDAO is a BioDAO (decentralized science organization) pioneering cryopreservation research funding through community governance. The organization operates as a platform combining the CRYO Governance Token (for voting and treasury management) with a Fellowship Program (micro-grants $100-$3,000) to fund cryopreservation projects. CryoDAO has funded multiple research initiatives including molecular profiling for cryoprotectants, whole organ cryopreservation, brain preservation studies, and a cryopreservation facility (STASIS). The platform connects researchers with funding through DAO governance, with over $5M in treasury and 6,000+ community members.

Product and service4 records
1CRYO Governance Token
CategoryGovernance and voting
Description

Token-based governance asset on Ethereum and Base blockchains that grants holders voting rights over CryoDAO treasury allocation and research funding proposals through Snapshot voting.

2CryoDAO Research Funding Platform
CategoryResearch funding and coordination
Description

Platform that channels community-governed treasury capital into cryopreservation, biostasis, and cryobiology research projects through structured grants and IP-NFT backflows.

3CryoDAO Fellowship Program
CategoryResearch funding and coordination
Description

Micro-grant fellowship program providing $100-$3,000 awards to researchers, students, and scientists working in cryopreservation and biostasis fields.

4IP-NFT Framework
CategoryIntellectual property tokenization
Description

Framework for tokenizing intellectual property rights from funded research projects into project-specific sub-DAOs, enabling the CryoDAO community to collectively own and benefit from research commercialization.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

VitaDAO is a Longevity Research DAO focused on funding longevity research. CryoDAO operates in a complementary space focused on cryopreservation. Both are BioDAOs pioneering decentralized science and share community members and governance principles.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tomorrow Bio is a cryonics provider partnering on the American Biostasis Foundation (STASIS) project to develop purpose-built long-term cryopreservation facilities. They will store patients at the ABF facility from day one.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cryopets is a cryonics provider for pets. Co-founded by CryoDAO co-founder Kai Micah Mills. Partnering on the STASIS project for cryopreservation facility development and patient storage.

Strategic tierCoreTypeTechnology or Integration
Description

Advanced Neural Biosciences is a cryobiology lab conducting neural cryopreservation research. Led by neuroscientist Chana Phaedra and human cryopreservation expert Aschwin de Wolf. Executing the CRYORAT project (high sub-zero preservation and revival of a rat) for CryoDAO.

5European Biostasis Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

European Biostasis Foundation opened the world's first purpose-built long-term cryopreservation facility in Switzerland in 2022. CryoDAO co-founder Dr. Emil Kendziorra is President of the Board. Sharing operational expertise for the STASIS project.

cryodao.org
6Oxford Cryotechnology
Strategic tierCoreTypeTechnology or Integration
Description

Oxford Cryotechnology is a research organization conducting molecular profiling and computational modelling for novel cryoprotectants. Led by Prof. Joao Pedro de Magalhaes and Dr. Roman Bauer. CryoDAO core member Emil Kendziorra is a minority shareholder.

cryodao.org
7Gaia Life
Strategic tierCoreTypeTechnology or Integration
Description

Gaia Life is a biotechnology company conducting the Live Births from Vitrified and Replanted Whole Ovaries project. Using proprietary nanowarming technology and isochoric preservation. Funding from CryoDAO ($350K) with NIH co-funding for the research.

cryodao.org
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DeSci DAO launchpad and shared service platform for BioDAOs including CryoDAO. Direct peer providing launch infrastructure and operational tooling for new decentralized science organizations.

TypeDirect peer
Description

Longevity research DAO using token-based governance to fund aging and longevity science. Direct peer sharing the same BioDAO/DeSci model, community overlap, and co-founder Vincent Weisser, with a complementary but adjacent research focus.

TypeBroad incumbent
Description

Cryobiology research company led by Dr. Gregory Fahy, scientific advisor to CryoDAO. Broad incumbent in cryoprotectant science and vitrification research, providing a traditional commercial contrast to CryoDAO's DAO model.

TypeBroad incumbent
Description

Pet cryopreservation provider founded by CryoDAO co-founder Kai Micah Mills. Broad incumbent operating at the commercial endpoint of the cryopreservation value chain with direct strategic alignment via co-founder overlap.

TypeBroad incumbent
Description

Cryonics provider offering human cryopreservation services in Europe. Broad incumbent in the cryopreservation value chain — strategic partner on the STASIS facility, led by CryoDAO co-founder Dr. Emil Kendziorra.

TypeDirect peer
Description

Decentralized science funding DAO and listed financial partner of CryoDAO. Same DeSci funding model with overlapping community and capital pool for early-stage biotech research.

TypeBroad incumbent
Description

Established US-based cryonics non-profit founded in 1972. Broad incumbent in cryopreservation services and biostasis research funding, with longer operational track record but more centralized governance model.

TypeDirect peer
Description

Biostasis-focused DAO co-founded alongside CryoDAO by the same team. Same funding and IP-NFT model, closely overlapping mission in human preservation research.

TypeDirect peer
Description

Decentralized platform for scientific research collaboration and peer review using token incentives. Direct peer in the DeSci ecosystem addressing a different stage of the research lifecycle but with comparable community-governance funding model.

TypeDirect peer
Description

DeSci platform providing IP-NFT infrastructure for tokenizing biopharma intellectual property. Direct infrastructure peer — CryoDAO's IP-NFT framework is built on Molecule's tooling and Program Manager Leonard Boltz supports both organizations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CryoDAO

Decentralized Science Fundingcryodao.org

CryoDAO is a Basel-registered decentralized autonomous organization that funds cryopreservation and biostasis research through community governance, serving researchers and longevity-focused crypto community members with a $5M+ treasury across nine funded projects.

What CryoDAO does

CryoDAO is a decentralized autonomous organization (DAO) registered as a non-profit association in Basel, Switzerland, that funds high-impact cryopreservation, biostasis, and cryobiology research through token-based community governance. The organization operates within the decentralized science (DeSci) ecosystem, with holders of the CRYO governance token proposing and voting on research funding allocations via Snapshot and on-chain voting. Its treasury exceeds $5 million, its community spans 6,000+ members across Discord and Twitter/X, and its CRYO token trades on Uniswap (Ethereum mainnet) and Aerodrome (Base chain).

The organization's core products are the CRYO governance token and the IP-NFT framework for tokenizing and community-governing research intellectual property. To date CryoDAO has funded nine research projects including CRYORAT ($900K for high-subzero preservation and revival of a rat, led by Advanced Neural Biosciences), Live Births from Vitrified Ovaries ($350K with Gaia Life and NIH co-funding), the American Biostasis Foundation STASIS facility ($100K, Comfort Texas), the CPA Repository ($52K), a Space Mice embryo cryopreservation project ($17.5K), the Multi-Organ Cryopreservation HIFU project (€50K), and the CryoDAO Fellowship program ($100-$3,000 micro-grants). Strategic scientific and operational partners include VitaDAO, Tomorrow Bio, Cryopets, European Biostasis Foundation, Oxford Cryotechnology, Advanced Neural Biosciences, and Gaia Life; the co-founder team includes Dr. Emil Kendziorra (CEO of Tomorrow Bio), Kai Micah Mills (Founder & CEO of Cryopets, Thiel Fellow), Eli Mohamad (X-Therma), and Vincent Weisser (co-initiator of VitaDAO & BIO).

CryoDAO does not generate traditional revenue and does not operate a conventional pricing model. Its economic model relies on token-based governance participation, potential returns from IP-NFT commercialization and licensing rights acquired from funded projects (which may flow back to the treasury), and treasury investment management. The Fellowship program is a non-dilutive micro-grant mechanism; the DAO does not take equity or IP in fellowship recipients. Primary stakeholder segments are cryopreservation researchers and scientists, DeFi/crypto community members holding CRYO for governance participation, and longevity and life-extension enthusiasts. Geographic restrictions under Regulation S limit CRYO token holdings by US persons, narrowing the addressable US retail market.

CryoDAO firmographics

Firmographics
Name
CryoDAO
Legal name
CryoDAO
Website
https://cryodao.org
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
CryoDAO is a Basel-registered decentralized autonomous organization that funds cryopreservation and biostasis research through community governance, serving researchers and longevity-focused crypto community members with a $5M+ treasury across nine funded projects.
Ownership category
akta.pro rank

CryoDAO industry classification

Industry
Product category
Decentralized Science Funding
NAICS
Grantmaking Foundations (813211)
SIC
Finance Services (6199)
akta.pro industry
PRIMARYFSAPAHAC
Governance Frameworks & DAO Tooling (modules, templates, standards)
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSAPAHAE
Grants, Funding & Budget Allocation Platforms
Financial & Insurance/Blockchain & Web3/DAO & Governance Platforms (voting, treasury, coordination tools)
SECONDARYFSADAMAL
DAO Treasury, Governance & On-Chain Finance Tools
Financial & Insurance/Crypto & Digital Assets/Decentralized Finance (DeFi) Platforms
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

Keywords

  • Decentralized science funding
  • Cryopreservation research grants
  • DAO governance infrastructure
  • Biostasis research platform
  • Intellectual property NFTs

Where CryoDAO is headquartered

Location

Headquarters

HQ city
Zug
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

CryoDAO business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Treasury Investment Returns: In return for funding research, CryoDAO may receive IP/commercialization rights and/or equity. Value created through funded projects flows back into the DAO to fund more research.
  2. Token-Based Governance: CRYO token serves as governance token for DAO membership. Value accrues to token holders through successful project outcomes and IP-NFT spinouts.
  3. IP-NFT Token Sales: IP-NFT launch generates proceeds through token sales. 50% of funds raised become immediately available for CryoDAO Treasury, the rest funds sub-DAO operating budget.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goCryoDAO Fellowship micro-grants

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

CryoDAO product offering

Product offering

Core offering

CryoDAO is a Decentralized Autonomous Organization that funds cryopreservation, biostasis, and cryobiology research through community-governed treasury allocation. It operates the CRYO governance token, an IP-NFT framework that tokenizes intellectual property from funded research for community ownership, and a fellowship program providing micro-grants to researchers. Revenue flows back to the DAO from treasury investment returns and IP/commercialization royalties from funded projects.

Product overview

CryoDAO is a BioDAO (decentralized science organization) pioneering cryopreservation research funding through community governance. The organization operates as a platform combining the CRYO Governance Token (for voting and treasury management) with a Fellowship Program (micro-grants $100-$3,000) to fund cryopreservation projects. CryoDAO has funded multiple research initiatives including molecular profiling for cryoprotectants, whole organ cryopreservation, brain preservation studies, and a cryopreservation facility (STASIS). The platform connects researchers with funding through DAO governance, with over $5M in treasury and 6,000+ community members.

Differentiator

Problem solved

Functional benefit

Products and services

  • CRYO Governance Token Token-based governance asset on Ethereum and Base blockchains that grants holders voting rights over CryoDAO treasury allocation and research funding proposals through Snapshot voting.
  • CryoDAO Research Funding Platform Platform that channels community-governed treasury capital into cryopreservation, biostasis, and cryobiology research projects through structured grants and IP-NFT backflows.
  • CryoDAO Fellowship Program Micro-grant fellowship program providing $100-$3,000 awards to researchers, students, and scientists working in cryopreservation and biostasis fields.
  • IP-NFT Framework Framework for tokenizing intellectual property rights from funded research projects into project-specific sub-DAOs, enabling the CryoDAO community to collectively own and benefit from research commercialization.

Quantifiable outcome

  • 6+ research projects funded with over $1.5M in total funding allocated

Companies that use CryoDAO

Customer profile

Segments3 records

Ideal customer profiles3 records

CryoDAO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature2 records

CryoDAO partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • VitaDAOcoreStrategic or Co-development PartnerVitaDAO is a Longevity Research DAO focused on funding longevity research. CryoDAO operates in a complementary space focused on cryopreservation. Both are BioDAOs pioneering decentralized science and share community members and governance principles.
  • Tomorrow BiocoreStrategic or Co-development PartnerTomorrow Bio is a cryonics provider partnering on the American Biostasis Foundation (STASIS) project to develop purpose-built long-term cryopreservation facilities. They will store patients at the ABF facility from day one.
  • CryopetscoreStrategic or Co-development PartnerCryopets is a cryonics provider for pets. Co-founded by CryoDAO co-founder Kai Micah Mills. Partnering on the STASIS project for cryopreservation facility development and patient storage.
  • Advanced Neural BiosciencescoreTechnology or IntegrationAdvanced Neural Biosciences is a cryobiology lab conducting neural cryopreservation research. Led by neuroscientist Chana Phaedra and human cryopreservation expert Aschwin de Wolf. Executing the CRYORAT project (high sub-zero preservation and revival of a rat) for CryoDAO.
  • European Biostasis FoundationcoreStrategic or Co-development PartnerEuropean Biostasis Foundation opened the world's first purpose-built long-term cryopreservation facility in Switzerland in 2022. CryoDAO co-founder Dr. Emil Kendziorra is President of the Board. Sharing operational expertise for the STASIS project.
  • Oxford CryotechnologycoreTechnology or IntegrationOxford Cryotechnology is a research organization conducting molecular profiling and computational modelling for novel cryoprotectants. Led by Prof. Joao Pedro de Magalhaes and Dr. Roman Bauer. CryoDAO core member Emil Kendziorra is a minority shareholder.
  • Gaia LifecoreTechnology or IntegrationGaia Life is a biotechnology company conducting the Live Births from Vitrified and Replanted Whole Ovaries project. Using proprietary nanowarming technology and isochoric preservation. Funding from CryoDAO ($350K) with NIH co-funding for the research.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

CryoDAO competitors and assessment

Company assessment

Direct peers

  • Bio.xyz: DeSci DAO launchpad and shared service platform for BioDAOs including CryoDAO. Direct peer providing launch infrastructure and operational tooling for new decentralized science organizations.
  • VitaDAO: Longevity research DAO using token-based governance to fund aging and longevity science. Direct peer sharing the same BioDAO/DeSci model, community overlap, and co-founder Vincent Weisser, with a complementary but adjacent research focus.
  • Beaker DAO: Decentralized science funding DAO and listed financial partner of CryoDAO. Same DeSci funding model with overlapping community and capital pool for early-stage biotech research.
  • HydraDAO: Biostasis-focused DAO co-founded alongside CryoDAO by the same team. Same funding and IP-NFT model, closely overlapping mission in human preservation research.
  • ResearchHub: Decentralized platform for scientific research collaboration and peer review using token incentives. Direct peer in the DeSci ecosystem addressing a different stage of the research lifecycle but with comparable community-governance funding model.
  • Molecule: DeSci platform providing IP-NFT infrastructure for tokenizing biopharma intellectual property. Direct infrastructure peer — CryoDAO's IP-NFT framework is built on Molecule's tooling and Program Manager Leonard Boltz supports both organizations.

Broad incumbents

  • 21st Century Medicine: Cryobiology research company led by Dr. Gregory Fahy, scientific advisor to CryoDAO. Broad incumbent in cryoprotectant science and vitrification research, providing a traditional commercial contrast to CryoDAO's DAO model.
  • Cryopets: Pet cryopreservation provider founded by CryoDAO co-founder Kai Micah Mills. Broad incumbent operating at the commercial endpoint of the cryopreservation value chain with direct strategic alignment via co-founder overlap.
  • Tomorrow Bio: Cryonics provider offering human cryopreservation services in Europe. Broad incumbent in the cryopreservation value chain — strategic partner on the STASIS facility, led by CryoDAO co-founder Dr. Emil Kendziorra.
  • Alcor Life Extension Foundation: Established US-based cryonics non-profit founded in 1972. Broad incumbent in cryopreservation services and biostasis research funding, with longer operational track record but more centralized governance model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CryoDAO social profiles

Digital presence

CryoDAO compliance and trust

Trust signal

Compliance2 records

CryoDAO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CryoDAO leadership team

Management profile

Number of profiles

Profiles15 records

CryoDAO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CryoDAO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CryoDAO

What does CryoDAO do?

CryoDAO is a Decentralized Autonomous Organization that funds cryopreservation, biostasis, and cryobiology research through community-governed treasury allocation. It operates the CRYO governance token, an IP-NFT framework that tokenizes intellectual property from funded research for community ownership, and a fellowship program providing micro-grants to researchers. Revenue flows back to the DAO from treasury investment returns and IP/commercialization royalties from funded projects.

Is CryoDAO a public or private company?

CryoDAO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CryoDAO founded?

CryoDAO was founded in 2022. It employs 1 to 10 people.

Where is CryoDAO based?

CryoDAO is headquartered in Zug, Switzerland, in the Europe region.

How does CryoDAO make money?

Three revenue lines are on record. Treasury Investment Returns are the primary driver. The others are token-Based Governance and IP-NFT Token Sales.

Who are CryoDAO's main competitors?

Direct peers on record are Bio.xyz, VitaDAO, Beaker DAO, HydraDAO, ResearchHub and Molecule. Broad incumbents are 21st Century Medicine, Cryopets, Tomorrow Bio and Alcor Life Extension Foundation.

Does CryoDAO have an API?

No public API is recorded for CryoDAO.

What industry is CryoDAO in?

CryoDAO's product category is Decentralized Science Funding. Its primary akta.pro industry code is FSAPAHAC, Governance Frameworks & DAO Tooling (modules, templates, standards), with a secondary code of FSAPAHAE, Grants, Funding & Budget Allocation Platforms. Its NAICS code is 813211 and its SIC code is 6199.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales